She/her/hers
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Basmattee Boodram, Jonathan Ozik, Harel Dahari
2021 – 2026 Continue Reading Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions
National Institutes of Health, National Institute on Drug Abuse
People: Basmattee Boodram
2017 – 2024 Continue Reading Contextual risk factors for hepatitis C among young persons who inject drugs
National Institutes of Health, National Institute of General Medical Sciences
People: Basmattee Boodram, Jonathan Ozik, Harel Dahari, Preeti Dubey
2017 – 2024 Continue Reading Computational discovery of effective hepatitis C intervention strategies
National Institutes of Health, National Center for Hivaids, Viral Hepatitis, Std, and Tb Prevention
People: Basmattee Boodram
2012 – 2014 Continue Reading Case Management and Linkage to Care Among Persons Who Inject Drugs
Kristensen K, Williams LD, Kaplan C, Pineros J, Lee E, Kaufmann M, Mackesy-Amiti ME, Boodram B. (2026). A Novel Index Measure of Housing-Related Risk as a Predictor of Overdose Among Young People Who Inject Drugs and Injection Networks. Journal of urban health : bulletin of the New York Academy of Medicine
Tatara E, Shekhtman L, Collier N, Cotler SJ, Mackesy-Amiti ME, Boodram B, Dahari H, Major M, Ozik J. (2026). Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject Drugs. Open forum infectious diseases, 13(6)
Kristensen K, Boodram B, Avila W, Pineros J, Latkin C, Mackesy-Amiti ME. (2025). Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago. PloS one, 20(1)
Williams LD, Nowlin J, Rodriguez WA, Boodram B. (2025). Testing the Relationships Between Multiple Domains of Substance Use‑Related Stigma and Depression Among a Sample of Young (18-30‑Year‑Old) People Who Inject Drugs in the Greater Chicago Area. International journal of mental health and addiction, 23(2)
Mackesy-Amiti ME, Gutfraind A, Tatara E, Collier NT, Cotler SJ, Page K, Ozik J, Boodram B, Major M, Dahari H. (2025). Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing. PNAS nexus, 4(1)
Schneider JA, Smith LR, Bouris AM, Oser C, Pho MT, Boodram B, Minardi S, Hondal ET, Ozik J, Taylor BG, Harawa NT, Salisbury-Afshar E, Rudes DS, Brewer RA, Hotton AL, Pettus C, Pollack HA, Taxman FS, Hulsey J. (2025). A taxonomy of social support interventions for People experiencing a syndemic of substance use disorder, criminal legal involvement, and downstream Health sequelae. SSM. Mental health, (7)
Bradley H, Luisi N, Carter A, Pigott TD, Abramovitz D, Allen ST, Asher A, Austin C, Bartholomew TS, Baum M, Board A, Boodram B, Borquez A, Brookmeyer KA, Buchacz K, Burnett J, Cooper HLF, Crepaz N, Debeck K, Feinberg J, Fong C, Freeman E, Furukawa NW, Genberg B, Gorbach P, Hagan H, Hayashi K, Huriaux E, Hurley H, Keruly J, Kristensen K, Lai S, Martin NK, Mateu-Gelabert P, Mcclain GM Jr., Mehta S, Mok WY, Reynoso M, Strathdee S, Torigian N, Weng CA, Westergaard R, Young A, Jarlais DCD. (2024). Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model. AIDS (London, England)
Tatara E, Lin Q, Ozik J, Kolak M, Collier N, Halpern D, Anselin L, Dahari H, Boodram B, Schneider J. (2024). Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios. PLoS computational biology, 20(7)
Chiu R, Tatara E, Mackesy-Amiti ME, Page K, Ozik J, Boodram B, Dahari H, Gutfraind A. (2024). Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs. Healthcare (Basel, Switzerland), 12(6)
Tatara E, Ozik J, Pollack HA, Schneider JA, Friedman SR, Harawa NT, Boodram B, Salisbury-Afshar E, Hotton A, Ouellet L, Mackesy-Amiti ME, Collier N, Macal CM. (2024). Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA network open, 7(12)
Tatara E, Lin Q, Ozik J, Kolak M, Collier N, Halpern D, Anselin L, Dahari H, Boodram B, Schneider J. (2023). Modeling the impact of spatial inequities in access to medications for treatment of opioid use disorder among persons who inject drugs. medRxiv : the preprint server for health sciences
Boodram B, Mackesy-Amiti ME, Khanna A, Brickman B, Dahari H, Ozik J. (2022). People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination. PloS one, 17(1)
Tatara E, Gutfraind A, Collier NT, Echevarria D, Cotler SJ, Major ME, Ozik J, Dahari H, Boodram B. (2022). Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago. PloS one, 17(3)
Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. (2021). Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective. Soc Sci Med
Hotton A, Mackesy-Amiti ME, Boodram B. (2021). Trends in homelessness and injection practices among young urban and suburban people who inject drugs: 1997-2017. Drug Alcohol Depend
Tatara E, Schneider J, Quasebarth M, Collier N, Pollack H, Boodram B, Friedman S, Salisbury-Afshar E, Mackesy-Amiti ME, Ozik J. (2021). Application of Distributed Agent-based Modeling to Investigate Opioid Use Outcomes in Justice Involved Populations. IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum : [proceedings]. IEEE International Symposium on Parallel & Distributed Processing, Workshops and Phd Forum, (2021)
Tilmon S, Aronsohn A, Boodram B, Canary L, Goel S, Hamlish T, Kemble S, Lauderdale DS, Layden J, Lee K, Millman AJ, Nelson N, Ritger K, Rodriguez I, Shurupova N, Wolf J, Johnson D.. (2021). HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago. J Public Health (Oxf)
Leslie D Williams, Mary Ellen Mackesy-Amiti, Carl Latkin, Basmattee Boodram. (2021). Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs. Drug Alcohol Depend
Mackesy-Amiti ME, Boodram B, Donenberg G. (2020). Negative affect, affect-related impulsivity, and receptive syringe sharing among people who inject drugs. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
Boodram B, Kaufmann M, Aronsohn A, Hamlish T, Peregrine Antalis E, Kim K, Wolf J, Rodriguez I, Millman AJ, Johnson D. Case Management and Capacity Building to Enhance Hepatitis C Treatment Uptake at Community Health Centers in a Large Urban Setting. Family & community health, 43(2)
Latkin CA, Dayton L, Strickland JC, Colon B, Rimal R, Boodram B. (2020). An Assessment of the Rapid Decline of Trust in US Sources of Public Information about COVID-19. J Health Commun, 25(10)
Tatara E, Collier NT, Ozik J, Gutfraind A, Cotler SJ, Dahari H, Major M, Boodram B. (2019). MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS. Proceedings of the ... Winter Simulation Conference. Winter Simulation Conference, (2019)
Echevarria D, Gutfraind A, Boodram B, Layden J, Ozik J, Page K, Cotler SJ, Major M, Dahari H. (2019). Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago. Vaccine, 37(19)
Mackesy-Amiti ME, Boodram B. (2018). Feasibility of ecological momentary assessment to study mood and risk behavior among young people who inject drugs. Drug and alcohol dependence, (187)
Major M, Gutfraind A, Shekhtman L, Cui Q, Kachko A, Cotler SJ, Hajarizadeh B, Sacks-Davis R, Page K, Boodram B, Dahari H. (2018). Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Science translational medicine, 10(449)
Dahari H, Boodram B. (2018). How to eliminate HCV in people who inject drugs in the USA. The Lancet. Infectious diseases, 18(2)
Boodram B, Hotton AL, Shekhtman L, Gutfraind A, Dahari H. (2018). High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members. Journal of urban health : bulletin of the New York Academy of Medicine, 95(1)
Hotton AL, Boodram B. (2017). Gender, Transience, Network Partnerships and Risky Sexual Practices Among Young Persons who Inject Drugs. AIDS and behavior, 21(4)
Gutfraind A, Boodram B, Prachand N, Hailegiorgis A, Dahari H, Major ME. (2015). Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections. PlOS One, 10(9)
Echevarria D, Gutfraind A, Boodram B, Major M, Del Valle S, Cotler SJ, Dahari H. (2015). Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago. PLoS One, 10(8)
Boodram B, Mackesy-Amiti ME, Latkin C. (2015). The role of social networks and geography on risky injection behaviors of young persons who inject drugs. Drug and alcohol dependence, (154)
Latkin CA, Davey-Rothwell MA, Knowlton AR, Alexander KA, Williams CT, Boodram B. (2013). Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. Journal of acquired immune deficiency syndromes (1999), (63 Suppl 1)
Boodram B, Hershow RC, Cotler SJ, Ouellet LJ. (2011). Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users. Drug and alcohol dependence, 119(3)
Boodram B, Hershow RC, Klinzman D, Stapleton JT. (2011). GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection. Journal of viral hepatitis, 18(4)
Boodram B, Golub ET, Ouellet LJ. (2010). Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago. Drug and alcohol dependence, 111(1-2)
Boodram B, Plankey MW, Cox C, Tien PC, Cohen MH, Anastos K, Karim R, Hyman C, Hershow RC. (2009). Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. AIDS patient care and STDs, 23(12)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.